Clinical significance of high anti-Entamoeba histolytica antibody titer in asymptomatic HIV-1-infected individuals

Journal of Infectious Diseases

Volumn 209, Issue 11, 2014, Pages 1801-1807

  Watanabe, Koji ^a,b   Aoki, Takahiro ^a   Nagata, Naoyoshi ^a   Tanuma, Junko ^a   Kikuchi, Yoshimi ^a   Oka, Shinichi ^a,b   Gatanaga, Hiroyuki ^a,b  

^a NATIONAL CENTER FOR GLOBAL HEALTH AND MEDICINE   (Japan)

^b KUMAMOTO UNIVERSITY   (Japan)

Author keywords

amebiasis; anti E. histolytica antibody; Entamoeba histolytica; HIV 1; seroprevalence

Indexed keywords

ENTAMOEBA HISTOLYTICA ANTIBODY; PARASITE ANTIBODY; UNCLASSIFIED DRUG;

ADULT; AGED; AMEBIASIS; ANTIBODY DETECTION; ANTIBODY TITER; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE EXACERBATION; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SEROPREVALENCE;

AMEBIASIS; ANTI-E. HISTOLYTICA ANTIBODY; ENTAMOEBA HISTOLYTICA; HIV-1; SEROPREVALENCE;

ADOLESCENT; ADULT; AGED; ANTIBODIES, PROTOZOAN; COHORT STUDIES; ENTAMOEBA HISTOLYTICA; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SEROEPIDEMIOLOGIC STUDIES; YOUNG ADULT;

EID: 84900540502     PISSN: 00221899     EISSN: 15376613     Source Type: Journal    
DOI: 10.1093/infdis/jit815     Document Type: Article

References (32)

1. Walsh JA. Problems in recognition and diagnosis of amebiasis: estimation of the global magnitude of morbidity and mortality. Rev Infect Dis 1986; 8: 228-38.
2. Hung CC, Chang SY, Ji DD. Entamoeba histolytica infection in men who have sex with men. Lancet Infect Dis 2012; 12: 729-36.
3. James R, Barratt J, Marriott D, Harkness J, Stark D. Seroprevalence of Entamoeba histolytica infection among men who have sex with men in Sydney, Australia. Am J Trop Med Hyg 2010; 83: 914-6.
4. van Hal SJ, Stark DJ, Fotedar R, Marriott D, Ellis JT, Harkness JL. Amoebiasis: current status in Australia. Med J Aust 2007; 186: 412-6.
5. Chen YM, Kuo SH. HIV-1 in Taiwan. Lancet 2007; 369: 623-5.
6. Lee JH, Kim GJ, Choi BS, et al. Increasing late diagnosis in HIV infection in South Korea: 2000-2007. BMC Public Health 2010; 10: 411.
7. van Griensven F, de Lind van Wijngaarden JW. A review of the epidemiology of HIV infection and prevention responses among MSM in Asia. AIDS 2010; 24:S30-40.
8. Annual surveillance report of HIV/AIDS in Japan, 1997. AIDS Surveillance Committee, Ministry of Health and Welfare, Japan. Working Group of Annual AIDS Surveillance, Ministry of Health and Welfare, Japan. Jpn J Infect Dis 1999; 52: 55-87.
9. Tsai JJ, Sun HY, Ke LY, et al. Higher seroprevalence of Entamoeba histolytica infection is associated with human immunodeficiency virus type 1 infection in Taiwan. Am J Trop Med Hyg 2006; 74: 1016-9.
10. Ohnishi K, Kato Y, Imamura A, Fukayama M, et al. Present characteristics of symptomatic Entamoeba histolytica infection in the big cities of Japan. Epidemiol Infect 2004; 132: 57-60.
11. Park WB, Choe PG, Jo JH, et al. Amebic liver abscess in HIV-infected patients, Republic of Korea. Emerg Infect Dis 2007; 13: 516-7.
12. Hung CC, Chen PJ, HsiE. histolytica SM, et al. Invasive amoebiasis: an emerging parasitic disease in patients infected with HIV in an area endemic for amoebic infection. AIDS 1999; 13: 2421-8.
13. Hung CC, Deng HY, Hsiao WH, et al. Invasive amebiasis as an emerging parasitic disease in patients with human immunodeficiency virus type 1 infection in Taiwan. Arch Intern Med 2005; 165: 409-15.
14. Hung CC, Ji DD, Sun HY, et al. Increased risk for Entamoeba histolytica infection and invasive amebiasis in HIV seropositive men who have sex with men in Taiwan. PLoS Negl Trop Dis 2008; 2:e175. doi: 10.1371/journal.pntd.0000175. (Pubitemid 352002952)
15. Samie A, Barrett LJ, Bessong PO, et al. Seroprevalence of Entamoeba histolytica in the context of HIV and AIDS: the case of Vhembe district, in South Africa's Limpopo province. Ann Trop Med Parasitol 2010; 104: 55-63.
16. Stauffer W, Abd-Alla M, Ravdin JI. Prevalence and incidence of Entamoeba histolytica infection in South Africa and Egypt. Arch Med Res 2006; 37: 266-9.
17. del Carmen Sanchez-Guillen M, Velazpuez-Rojas M, Salgado-Rosas H, et al. Seroprevalence of anti-Entamoeba histolytica antibodies by IHA and ELISA assays in blood donors from Puebla, Mexico. Arch Med Res 2000; 31:S53-4.
18. Cross JH, Tsai SH. Indirect hemagglutination antibody titers for Entamoeba histolytica in dried filter paper blood and sera. Southeast Asian J Trop Med Public Health 1982; 13: 69-72.
19. Chacin-Bonilla L, Mathews H, Dikdan Y, Guanipa N. Seroepidemiologic study of amebiasis in a community of the State of Zulia, Venezuela. Rev Inst Med Trop Sao Paulo 1990; 32: 467-73.
20. Caballero-Salcedo A, Viveros-Rogel M, Salvatierra B, et al. Seroepidemiology of amebiasis in Mexico. Am J Trop Med Hyg 1994; 50: 412-9.
21. Uga S, Ono K, Kataoka N, Hasan H. Seroepidemiology of five major zoonotic parasite infections in inhabitants of Sidoarjo, East Java, Indonesia. Southeast Asian J Trop Med Public Health 1996; 27: 556-61.
22. Yang B, Chen Y, Wu L, Wu L, Tachibana H, Cheng X. Seroprevalence of Entamoeba histolytica infection in China. Am J Trop Med Hyg 2012; 87: 97-103.
23. Hung CC, Wu PY, Chang SY, et al. Amebiasis among persons who sought voluntary counseling and testing for human immunodeficiency virus infection: a case-control study. Am J Trop Med Hyg 2011; 84: 65-9.
24. Chang SY, Sun HY, Ji DD, et al. Cost-effectiveness of detection of intestinal amebiasis by using serology and specific-amebic-antigen assays among persons with or without human immunodeficiency virus infection. J Clin Microbiol 2008; 46: 3077-9.
25. Takeuchi T, Miyahira Y, Kobayashi S, Nozaki T, Motta SR, Matsuda J. High seropositivity for Entamoeba histolytica infection in Japanese homosexual men: further evidence for the occurrence of pathogenic strains. Trans R Soc Trop Med Hyg 1990; 84: 250-1.
26. Takeuchi T, Okuzawa E, Nozaki T, et al. High seropositivity of Japanese homosexual men for amebic infection. J Infect Dis 1989; 159: 808.
27. Watanabe K, Gatanaga H, Escueta-de C, Tanuma J, Nozaki T, Oka S. Amebiasis in HIV-1-infected Japanese men: clinical features and response to therapy. PLoS Negl Trop Dis 2011; 5:e1318. doi: 10.1371/journal.pntd.0001318.
28. Nagata N, Shimbo T, Akiyama J, et al. Risk factors for intestinal invasive amebiasis in Japan, 2003-2009. Emerg Infect Dis 2012; 18: 717-24.
29. Fotedar R, Stark D, Beebe N, Marriott D, Ellis J, Harkness J. Laboratory diagnostic techniques for Entamoeba species. Clin Microbiol Rev 2007; 20: 511-32.
30. Garcia LS, Bruckner DA, Brewer TC, Shimizu RY. Comparison of indirect fluorescent-antibody amoebic serology with counterimmunoelectrophoresis and indirect hemagglutination amoebic serologies. J Clin Microbiol 1982; 15: 603-5.
31. Haque R, Duggal P, Ali IM, et al. Innate and acquired resistance to amebiasis in Bangladeshi children. J Infect Dis 2002; 186: 547-52.
32. Jackson TF, Anderson CB, Simjee AE. Serological differentiation between past and present infection in hepatic amoebiasis. Trans R Soc Trop Med Hyg 1984; 78: 342-5.